Subscribe Now

Trending News

Blog Post

No evidence of benefit for chloroquine, hydroxychloroquine in Covid-19 patients, urgent randomised trials needed: Lancet
An Osang Healthcare employee works inside the compnay's laboratory on May 4.
News

No evidence of benefit for chloroquine, hydroxychloroquine in Covid-19 patients, urgent randomised trials needed: Lancet 

A new study, reported on Friday in The Lancet, has found that the use of chloroquine or hydroxychloroquine is linked to increased rates of mortality and heart arrhythmias among patients with Covid-19.

Authors of the study suggest these drug regimens should be used to treat Covid-19 outside of clinical trials and urgent confirmation from randomised clinical trials is needed.

Professor Dr Frank Ruschitzka, director of Heart Centre at University Hospital Zurich, who co-authored the study.

This is the largest observational study done so far. Clearly, the use of the drug for treating Covid-19 patient is harmful… It is reasonably safe to treat malaria. However, there is no benefit of this drug for Covid-19 patients. We have studied patients from across the world and there is no reason to assume Indian patients would do any better,” Dr Frank said.

Related posts

Leave a Reply

Required fields are marked *